Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Insoles for adult achondroplasia

Discussion in 'Biomechanics, Sports and Foot orthoses' started by crambo, Apr 11, 2013.

  1. crambo

    crambo Member


    Members do not see these Ads. Sign Up.
    Hi.

    Can anyone give any advice on the use of insoles for adult achondroplasia ( Dwarfism ).

    Many thanks.
     
  2. Craig Payne

    Craig Payne Moderator

    Articles:
    8
    Re: Insoles for adult achondrplasia

    No different to doing insoles or foot orthotics for anyone else:

    1. What hurts?
    2. What is the load in the tissue that is causing the hurt?
    3. Can a foot orthotic reduce that load?
    4. Design a foot orthotic with features to reduce that load.
     
  3. Admin2

    Admin2 Administrator Staff Member

    Related Thread:
    Achrondoplasia


    Achondroplasia

    Achondroplasia is a genetic disorder with an autosomal dominant pattern of inheritance whose primary feature is dwarfism.[3] It is the most common cause of dwarfism[4] and affects about 1 in 27,500 people.[3] In those with the condition, the arms and legs are short, while the torso is typically of normal length.[3] Those affected have an average adult height of 131 centimetres (4 ft 4 in) for males and 123 centimetres (4 ft) for females.[3] Other features can include an enlarged head with prominent forehead (frontal bossing)[3] and underdevelopment of the midface (midface hypoplasia).[6] Complications can include sleep apnea or recurrent ear infections.[3] Achondroplasia includes the extremely rare short-limb skeletal dysplasia with severe combined immunodeficiency.

    Achondroplasia is caused by a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene that results in its protein being overactive.[3] Achondroplasia results in impaired endochondral bone growth (bone growth within cartilage).[7] The disorder has an autosomal dominant mode of inheritance, meaning only one mutated copy of the gene is required for the condition to occur.[8] About 80% of cases occur in children of parents without the disease, and result from a new (de novo, or sporadic) mutation, which most commonly originates as a spontaneous change during spermatogenesis.[5] The rest are inherited from a parent with the condition.[3] The risk of a new mutation increases with the age of the father.[4] In families with two affected parents, children who inherit both affected genes typically die before birth or in early infancy from breathing difficulties.[3] The condition is generally diagnosed based on the clinical features but may be confirmed by genetic testing.[5] Mutations in FGFR3 also cause achondroplasia related conditions including hypochondroplasia and SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans), a rare disorder of bone growth characterized by skeletal, brain, and skin abnormalities resulting in severe short-limb skeletal dysplasia with severe combined immunodeficiency.[9]

    Treatments include small molecule therapy with a C-natriuretic peptide analog (vosoritide), approved to improve growth velocity in children with achondroplasia based on results in Phase 3 human trials, although its long-term effects are unknown.[10] Growth hormone therapy may also be used.[5] Efforts to treat or prevent complications such as obesity, hydrocephalus, obstructive sleep apnea, middle ear infections or spinal stenosis may be required.[5] Support groups support people with achondroplasia, including the Little People of America (LPA) and Growing Stronger. Nonprofit physician organizations also exist to disseminate information about treatment and management options, including development of patient resources.

    1. ^ "Achondroplasia". Lexico UK English Dictionary. Oxford University Press. Archived from the original on 11 December 2019.
    2. ^ "Achondroplasia". Merriam-Webster.com Dictionary.
    3. ^ a b c d e f g h i j k l m n "Achondroplasia". Genetics Home Reference. May 2012. Retrieved 12 December 2017.
    4. ^ a b c Cite error: The named reference Lancet2007 was invoked but never defined (see the help page).
    5. ^ a b c d e f g Pauli RM, Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Mefford HC, Stephens K, Amemiya A, Ledbetter N (2012). "Achondroplasia". GeneReviews. PMID 20301331.
    6. ^ White KK, Bompadre V, Goldberg MJ, Bober MB, Campbell JW, Cho TJ, Hoover-Fong J, Mackenzie W, Parnell SE, Raggio C, Rapoport DM, Spencer SA, Savarirayan R (1 January 2016). "Best practices in the evaluation and treatment of foramen magnum stenosis in achondroplasia during infancy". American Journal of Medical Genetics Part A. 170 (1): 42–51. doi:10.1002/ajmg.a.37394. ISSN 1552-4825. PMID 26394886. S2CID 22430204.
    7. ^ Pauli RM (2019). "Achondroplasia: A comprehensive clinical review". Orphanet Journal of Rare Diseases. 14 (1): 1. doi:10.1186/s13023-018-0972-6. PMC 6318916. PMID 30606190.
    8. ^ "Achondroplasia". Genetic and Rare Diseases Information Center (GARD) – an NCATS Program. 2016. Retrieved 12 December 2017.
    9. ^ Legare JM (1993), Adam MP, Feldman J, Mirzaa GM, Pagon RA (eds.), "Achondroplasia", GeneReviews®, Seattle (WA): University of Washington, Seattle, PMID 20301331, retrieved 15 December 2023
    10. ^ Cite error: The named reference :0 was invoked but never defined (see the help page).
     
  4. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Lower limb biomechanics during gait in children with Achondroplasia
    Damien Kiernan
    J Biomech. 2021 Feb 12;119
     
  5. NewsBot

    NewsBot The Admin that posts the news.

    Articles:
    1
    Gait in children with achondroplasia – a cross-sectional study on joint kinematics and kinetics
    Eva W. Broström, Lotte Antonissen, Johan von Heideken, Anna-Clara Esbjörnsson, Lars Hagenäs & Josefine E. Naili
    BMC Musculoskeletal Disorders volume 23, Article number: 397 (2022)
     
Loading...

Share This Page